APA (7th ed.) Citation

CX, M., MJ, E., GR, P., Z, G., SR, C., CE, R., . . . PM, F. (2013). A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer. Breast cancer research and treatment, 137(2), 483. https://doi.org/10.1007/s10549-012-2378-9

Chicago Style (17th ed.) Citation

CX, Ma, et al. "A Phase II Study of UCN-01 in Combination with Irinotecan in Patients with Metastatic Triple Negative Breast Cancer." Breast Cancer Research and Treatment 137, no. 2 (2013): 483. https://doi.org/10.1007/s10549-012-2378-9.

MLA (9th ed.) Citation

CX, Ma, et al. "A Phase II Study of UCN-01 in Combination with Irinotecan in Patients with Metastatic Triple Negative Breast Cancer." Breast Cancer Research and Treatment, vol. 137, no. 2, 2013, p. 483, https://doi.org/10.1007/s10549-012-2378-9.